Search Results - "Pohlmann PR"

Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.

Authors: Boughey JC Alvarado MD Lancaster RB et al.

Corporate Authors: Boughey JC Alvarado MD Lancaster RB et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2019 Jan 02; Vol. 5, pp. 2. Date of Electronic Publication: 2019 Jan 02 (Print Publication: 2019).

Publication Type: Journal Article; Published Erratum

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: eCollection Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors.

Authors: Magbanua MJM Manon NA Wolf DM et al.

Source: Nature communications [Nat Commun] 2025 Dec 09; Vol. 16 (1), pp. 9945. Date of Electronic Publication: 2025 Dec 09.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

A review: advances of curcumin co-delivery biomaterials-based system in anti-tumor therapy.

Authors: Fu, Yang Ge, Yuanxin Yi, Shixiong et al.

Source: Journal of Materials Science; May2025, Vol. 60 Issue 18, p7492-7506, 15p

Comparative efficacy of subsequent-line therapies for advanced triple-negative breast cancer: a bayesian network meta-analysis.

Authors: Xu, Zheng Ding, Linxian Zhao, Tai et al.

Source: Oncology Reviews. 2026, p1-12. 12p.

Effects of orally administered crofelemer on the incidence and severity of neratinib-induced diarrhea in female dogs.

Authors: Guy, Michael Teixeira, Andre Shrier, Allison et al.

Source: PLoS ONE. 1/24/2024, Vol. 19 Issue 1, p1-16. 16p.

Decoding the CAF-TAM axis: multi-omics dissection and therapeutic targeting of stromal-immune crosstalk in the tumor microenvironment.

Authors: Fu Y Li M Wu S et al.

Source: Cell death & disease [Cell Death Dis] 2026 Apr 18; Vol. 17 (1). Date of Electronic Publication: 2026 Apr 18.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE

The controversial role of metabolic reprogramming in anti-tumor therapy resistance.

Authors: Xu Y Wang Y Fu Q et al.

Source: Discover oncology [Discov Oncol] 2026 Mar 15; Vol. 17 (1). Date of Electronic Publication: 2026 Mar 15.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE

Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer.

Authors: Ciliberto, Gennaro Canfora, Marco Terrenato, Irene et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 10/17/2022, Vol. 41 Issue 1, p1-5. 5p.

This result is not displayed to guests.
Login for full access.

Exploring CAR cell therapies beyond CAR-T for myeloid malignancies.

Authors: Li YR Chen Y Yang L

Source: Journal of biomedical science [J Biomed Sci] 2026 Jun 04; Vol. 33 (1). Date of Electronic Publication: 2026 Jun 04.

Publication Type: Journal Article; Review

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 9421567 Publication Model: Electronic Cited Medium: Internet ISSN: 1423-0127 (Electronic) Linking ISSN: 10217770 NLM ISO Abbreviation: J Biomed Sci Subsets: MEDLINE

CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial.

Authors: Reiss KA Angelos MG Dees EC et al.

Source: Nature medicine [Nat Med] 2025 Apr; Vol. 31 (4), pp. 1171-1182. Date of Electronic Publication: 2025 Feb 07.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Specificity protein 1 initiates epithelial-mesenchymal transition of circulating tumor cells to inhibit metastasis in prostate cancer.

Authors: Yang, Mei Li, Lin Jie Qiu, Guo Ping et al.

Source: Cancer Cell International. 7/11/2025, Vol. 25 Issue 1, p1-12. 12p.

Metabolic engineering of SLC38A2 reprograms glutamine utilization and enhances CAR-macrophage antitumor function in solid tumors.

Authors: Liu, Mingzhu Chen, Qingxi Zhang, Luoling et al.

Source: Cancer Biology & Medicine. Mar2026, Vol. 23 Issue 3, p392-417. 32p.

Changes of perioperative cognitive function and its effect on quality of life in laryngeal cancer.

Authors: Gao, Zehui Jia, Lina Yao, Jianli et al.

Source: Perioperative Medicine. 3/13/2025, Vol. 14 Issue 1, p1-8. 8p.

Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer.

Authors: Lynce F Blackburn MJ Zhuo R et al.

Source: Cancer [Cancer] 2021 Oct 01; Vol. 127 (19), pp. 3622-3630. Date of Electronic Publication: 2021 Jun 22.

Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

In vivo CAR-cell therapy: current challenges and emerging therapeutic advances.

Authors: Yang YM Bao B Cao YH et al.

Source: Molecular biomedicine [Mol Biomed] 2026 Apr 20; Vol. 7 (1). Date of Electronic Publication: 2026 Apr 20.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Singapore Country of Publication: Singapore NLM ID: 9918283581406676 Publication Model: Electronic Cited Medium: Internet ISSN: 2662-8651 (Electronic) Linking ISSN: 26628651 NLM ISO Abbreviation: Mol Biomed Subsets: MEDLINE

Natural killer cells, macrophages and dendritic cells as innate immune therapies for blood cancers.

Authors: Oriquat G Abdulsahib WK Ismael SH et al.

Source: Annals of hematology [Ann Hematol] 2026 Mar 02; Vol. 105 (4). Date of Electronic Publication: 2026 Mar 02.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

Targeting metabolic dependencies to reverse chemoradiotherapy resistance in colorectal cancer.

Authors: Hellkamp M Gertken S Buchloh J et al.

Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2026 Jun 23; Vol. 45 (1). Date of Electronic Publication: 2026 Jun 23.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE

Head and neck squamous cell carcinoma: current and emerging therapeutic strategies.

Authors: Ahuja P Kadian L Goyal S et al.

Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2026 May 15. Date of Electronic Publication: 2026 May 15.

Publication Type: Journal Article; Review

Journal Info: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

A novel Chimeric Antigen Receptor (CAR) - strategy to target EGFR^VIII-mutated glioblastoma cells via macrophages.

Authors: Vera K Esken G Hwang JW et al.

Source: BMC cancer [BMC Cancer] 2026 May 08; Vol. 26 (1). Date of Electronic Publication: 2026 May 08.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE